Malignant lymphoma in the HIV-positive patient

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

(2017) Robert Chen et al.   JOURNAL OF CLINICAL ONCOLOGY

Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathy

(2017) Jose D. Sandoval-Sus et al.   Journal for ImmunoTherapy of Cancer

Brentuximab Vedotin in Patients With Relapsed HIV-Related Lymphoma

(2017) Mitul Gandhi et al.   Journal of the National Comprehensive Cancer Network

Diagnosis and Management of Castleman Disease

(2017) Jacob D. Soumerai et al.   Cancer Control

Safety and Efficacy of Combination Antiretroviral Therapy in Human Immunodeficiency Virus–Infected Adults Undergoing Autologous or Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

(2016) Christine Johnston et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial

(2016) J. C. Alvarnas et al.   BLOOD

Management and Outcomes of HIV-Associated Primary Effusion Lymphoma: A Single Center Experience

(2016) Arjun Gupta et al.   Clinical Lymphoma Myeloma & Leukemia

CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP

(2016) Norbert Schmitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

(2016) Anas Younes et al.   LANCET ONCOLOGY

Antiviral prophylaxis in patients with solid tumours and haematological malignancies—update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)

(2015) Michael Sandherr et al.   ANNALS OF HEMATOLOGY

The biology and treatment of plasmablastic lymphoma

(2015) J. J. Castillo et al.   BLOOD

Outcomes for HIV-positive patients with primary central nervous system lymphoma after high-dose chemotherapy and auto-SCT

(2015) A O'Neill et al.   BONE MARROW TRANSPLANTATION

Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma

(2015) Jorge J. Castillo et al.   BRITISH JOURNAL OF HAEMATOLOGY

High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort

(2015) Caroline Besson et al.   CLINICAL INFECTIOUS DISEASES

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Causes of death among HIV-infected patients in France in 2010 (national survey)

(2014) Philippe Morlat et al.   AIDS

Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era

(2014) Todd M. Gibson et al.   AIDS

Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort

(2014) Philipp Schommers et al.   BRITISH JOURNAL OF HAEMATOLOGY

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

(2014) Bruce D. Cheson et al.   JOURNAL OF CLINICAL ONCOLOGY

Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients

(2014) Blanca Xicoy et al.   LEUKEMIA & LYMPHOMA

Poor outcome of HIV-infected patients with plasmablastic lymphoma

(2013) Philipp Schommers et al.   AIDS

Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma

(2013) Thomas S. Uldrick et al.   AIDS

POEMS syndrome and Castleman disease

(2013) S. Andhavarapu et al.   BLOOD

Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients

(2013) S. K. Barta et al.   BLOOD

Is valganciclovir really effective in primary effusion lymphoma: case report of an HIV(−) EBV(−) HHV8(+) patient

(2013) Murat Ozbalak et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi

(2013) M. Merli et al.   HAEMATOLOGICA

Low-Intensity Therapy in Adults with Burkitt's Lymphoma

(2013) Kieron Dunleavy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Successful tocilizumab treatment in a patient with human herpesvirus 8-positive and human immunodeficiency virus-negative multicentric Castleman's disease of plasma cell type nonresponsive to rituximab-CVP therapy

(2012) Györgyi Műzes et al.   APMIS

Human immunodeficiency virus-associated plasmablastic lymphoma

(2012) Jorge J. Castillo et al.   CANCER

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

(2012) Silvia Montoto et al.   JOURNAL OF CLINICAL ONCOLOGY

Stage-Adapted Treatment of HIV-Associated Hodgkin Lymphoma: Results of a Prospective Multicenter Study

(2012) Marcus Hentrich et al.   JOURNAL OF CLINICAL ONCOLOGY

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

(2012) Anas Younes et al.   JOURNAL OF CLINICAL ONCOLOGY

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

(2012) Roland Schmitz et al.   NATURE

Treatment of AIDS-related lymphomas

(2011) Christoph Wyen et al.   AIDS

Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis

(2011) J. A. Barnes et al.   ANNALS OF ONCOLOGY

CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

(2011) N. Schmitz et al.   ANNALS OF ONCOLOGY

Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease

(2011) C. Hoffmann et al.   BLOOD

HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes

(2011) J. Bohlius et al.   BLOOD

Mortality after cancer diagnosis in HIV-infected individuals treated with antiretroviral therapy

(2010) Chad J Achenbach et al.   AIDS

How I treat HIV-associated multicentric Castleman disease

(2010) M. Bower   BLOOD

The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma

(2010) K. Dunleavy et al.   BLOOD

Cancer incidence in the multicenter aids cohort study before and during the HAART era

(2010) Eric C. Seaberg et al.   CANCER

Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States

(2010) Edgar P Simard et al.   CANCER

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

(2010) Jeremy S. Abramson et al.   CANCER

B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology

(2010) Antonino Carbone et al.   HUMAN PATHOLOGY

The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease

(2009) T. Powles et al.   ANNALS OF ONCOLOGY

Allogeneic Hematopoietic Cell Transplantation in Human Immunodeficiency Virus–Positive Patients with Hematologic Disorders: A Report from the Center for International Blood and Marrow Transplant Research

(2009) Vikas Gupta et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors

(2009) A. Re et al.   BLOOD

CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

(2009) V. Boehme et al.   BLOOD

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

(2009) J. A. Sparano et al.   BLOOD

Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic)

(2009) Charlotte Lewden et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Immunophenotypic Analysis of AIDS-Related Diffuse Large B-Cell Lymphoma and Clinical Implications in Patients From AIDS Malignancies Consortium Clinical Trials 010 and 034

(2009) Amy Chadburn et al.   JOURNAL OF CLINICAL ONCOLOGY

Highly Active Antiretroviral Therapy and the Incidence of Non–AIDS-Defining Cancers in People With HIV Infection

(2008) Thomas Powles et al.   JOURNAL OF CLINICAL ONCOLOGY